154 related articles for article (PubMed ID: 3744547)
1. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.
Vukajlovich SW
Infect Immun; 1986 Sep; 53(3):480-5. PubMed ID: 3744547
[TBL] [Abstract][Full Text] [Related]
2. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways.
Vukajlovich SW; Hoffman J; Morrison DC
Mol Immunol; 1987 Apr; 24(4):319-31. PubMed ID: 3309624
[TBL] [Abstract][Full Text] [Related]
3. Legionella pneumophila lipopolysaccharide activates the classical complement pathway.
Mintz CS; Schultz DR; Arnold PI; Johnson W
Infect Immun; 1992 Jul; 60(7):2769-76. PubMed ID: 1612744
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside modulation of lipopolysaccharide-initiated complement activation.
Morrison DC; Brown DE; Vukajlovich SW; Ryan JL
Mol Immunol; 1985 Oct; 22(10):1169-76. PubMed ID: 4079939
[TBL] [Abstract][Full Text] [Related]
5. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different requirements in physical state for the interaction of lipopolysaccharides with the classical and alternative pathways of complement.
Wilson ME; Morrison DC
Eur J Biochem; 1982 Nov; 128(1):137-41. PubMed ID: 6756918
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
Mashimo J; Mizutani T; Mita A; Kasai N
Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
[TBL] [Abstract][Full Text] [Related]
8. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes.
Münstermann M; Wiese A; Brandenburg K; Zähringer U; Brade L; Kawahara K; Seydel U
J Membr Biol; 1999 Feb; 167(3):223-32. PubMed ID: 9929374
[TBL] [Abstract][Full Text] [Related]
10. Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain.
Fujihara Y; Lei MG; Morrison DC
Infect Immun; 1993 Mar; 61(3):910-8. PubMed ID: 8432611
[TBL] [Abstract][Full Text] [Related]
11. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide.
Pollack M; Oishi K; Chia J; Evans M; Guelde G; Koles N
Adv Exp Med Biol; 1990; 256():331-40. PubMed ID: 1691578
[TBL] [Abstract][Full Text] [Related]
12. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
13. Interaction of purified lipoteichoic acid with the classical complement pathway.
Loos M; Clas F; Fischer W
Infect Immun; 1986 Sep; 53(3):595-9. PubMed ID: 3488963
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
[TBL] [Abstract][Full Text] [Related]
15. Activation of the complement system by Francisella tularensis lipopolysaccharide.
Fulop M; Webber T; Manchee R
New Microbiol; 1993 Apr; 16(2):141-7. PubMed ID: 8510568
[TBL] [Abstract][Full Text] [Related]
16. Effects of a streptococcal lipoteichoic acid on complement activation in vitro.
Monefeldt K; Tollefsen T
J Clin Periodontol; 1993 Mar; 20(3):186-92. PubMed ID: 8450083
[TBL] [Abstract][Full Text] [Related]
17. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
Morrison DC; Kline LF
J Immunol; 1977 Jan; 118(1):362-8. PubMed ID: 318670
[TBL] [Abstract][Full Text] [Related]
18. Preparation and binding specificity of a monoclonal antibody recognizing 3-deoxy-D-manno-2-octulosonic acid (Kdo) in lipopolysaccharides of Re chemotype.
Pedron T; Girard R; Kosma P; Chaby R
Hybridoma; 1992 Dec; 11(6):765-77. PubMed ID: 1294455
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
20. Activation of the classical complement pathway by a polysaccharide from sugar cane.
Li X; Vogt W
Immunopharmacology; 1982 Oct; 5(1):31-8. PubMed ID: 6813288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
